Filing Details
- Accession Number:
- 0001484612-22-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-04 16:29:54
- Reporting Period:
- 2022-01-03
- Accepted Time:
- 2022-01-04 16:29:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484612 | Outset Medical Inc. | OM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1304125 | Leslie Trigg | 3052 Orchard Drive San Jose CA 95134 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-03 | 20,000 | $3.88 | 270,567 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-03 | 20,000 | $47.10 | 250,567 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-03 | 12,500 | $3.88 | 263,067 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-03 | 12,500 | $47.10 | 250,567 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-01-03 | 10,000 | $3.88 | 260,567 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-03 | 10,000 | $47.09 | 250,567 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-03 | 20,000 | $0.00 | 20,000 | $3.88 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-03 | 12,500 | $0.00 | 12,500 | $3.88 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2022-01-03 | 10,000 | $0.00 | 10,000 | $3.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 138,211 | 2027-09-19 | No | 4 | M | Direct | |
| 125,711 | 2027-09-19 | No | 4 | M | Direct | |
| 115,711 | 2027-09-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 8,770 | Indirect | Trigg Family Trust |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2020.
- The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 1,040 shares; $46.00-$46.99 - 3,779 shares; $47.00-$47.99 - 15,181 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 775 shares; $46.00-$46.99 - 1,691 shares; $47.00-$47.99 - 10,034 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $45.00-$45.99 - 700 shares; $46.00-$46.99 - 1,784 shares; $47.00-$47.99 - 7,366; $48.00 - $48.99 - 150 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- This option vested in 48 equal monthly installments beginning on October 19, 2017.
Billionaire Hedge Funds
